Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2608
https://www.valueinhealthjournal.com/article/S1098-3015(14)04557-4/fulltext
Title :
Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04557-4&doi=10.1016/j.jval.2014.08.2608
First page :
A379
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
310